Open main menu

Oldest pages

Showing below up to 50 results in range #201 to #250.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Air-kerma, incident‏‎ (17:32, 12 September 2019)
  2. Air-kerma, product‏‎ (17:33, 12 September 2019)
  3. Alimentary tract transfer factor‏‎ (17:34, 12 September 2019)
  4. Alpha decay‏‎ (17:35, 12 September 2019)
  5. Alveolar-interstitial region‏‎ (17:35, 12 September 2019)
  6. Angiogenesis‏‎ (17:35, 12 September 2019)
  7. Annihilation photons‏‎ (17:36, 12 September 2019)
  8. Annual dose‏‎ (17:36, 12 September 2019)
  9. Area monitoring‏‎ (17:37, 12 September 2019)
  10. Auger transition‏‎ (17:37, 12 September 2019)
  11. Authorization‏‎ (17:38, 12 September 2019)
  12. Authorized limit‏‎ (17:38, 12 September 2019)
  13. Autoimmune disease‏‎ (17:39, 12 September 2019)
  14. Autonomy‏‎ (17:39, 12 September 2019)
  15. Averted dose‏‎ (17:40, 12 September 2019)
  16. Wisdom‏‎ (17:43, 12 September 2019)
  17. Waste disposal‏‎ (17:43, 12 September 2019)
  18. Background dose (rate)‏‎ (18:55, 12 September 2019)
  19. Basal cell‏‎ (18:56, 12 September 2019)
  20. Benthic‏‎ (18:57, 12 September 2019)
  21. Beta-minus decay‏‎ (18:57, 12 September 2019)
  22. Beta-plus decay‏‎ (18:58, 12 September 2019)
  23. Biomedical research volunteer‏‎ (18:58, 12 September 2019)
  24. Bioturbation‏‎ (18:59, 12 September 2019)
  25. Bone marrow‏‎ (18:59, 12 September 2019)
  26. Bradycardia‏‎ (18:59, 12 September 2019)
  27. Branching fraction‏‎ (18:59, 12 September 2019)
  28. Bronchial region‏‎ (19:00, 12 September 2019)
  29. Bystander effect‏‎ (19:00, 12 September 2019)
  30. Qualified expert‏‎ (19:03, 12 September 2019)
  31. Occupational exposure‏‎ (19:07, 12 September 2019)
  32. Orphan source‏‎ (19:07, 12 September 2019)
  33. Oversight‏‎ (19:07, 12 September 2019)
  34. Cardiac arrhythmias‏‎ (19:15, 12 September 2019)
  35. Cardiac valve diseases‏‎ (19:16, 12 September 2019)
  36. Cardiomyopathy‏‎ (19:16, 12 September 2019)
  37. Cardioverter-defibrillator‏‎ (19:16, 12 September 2019)
  38. Chronic exposure‏‎ (19:17, 12 September 2019)
  39. Class SR-0 gases‏‎ (19:17, 12 September 2019)
  40. Class SR-1 gases‏‎ (19:17, 12 September 2019)
  41. Class SR-2 gases‏‎ (19:18, 12 September 2019)
  42. Clearance level‏‎ (19:19, 12 September 2019)
  43. Clonogenic cells‏‎ (19:19, 12 September 2019)
  44. Clonogenic survival‏‎ (19:19, 12 September 2019)
  45. Co-expertise‏‎ (19:19, 12 September 2019)
  46. Colony‏‎ (19:20, 12 September 2019)
  47. Committed effective dose‏‎ (19:20, 12 September 2019)
  48. Committed equivalent dose‏‎ (19:20, 12 September 2019)
  49. Complex tissues‏‎ (19:21, 12 September 2019)
  50. Computed tomography dose index‏‎ (19:21, 12 September 2019)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)